NIH-funded research Career grant

Glycan signals in neutrophils and pneumonia risk after brain injury

Official title: The Role of Neutrophil Glycosylation in Susceptibility to Pneumonia After Traumatic Brain Injury

Funded at Beth Israel Deaconess Medical Center · NIH-11451948 · Data updated 2026-11-12

This grant explores how immune Cells in people with brain injury may become more prone to pneumonia due to changes in sugars on their cells, with the goal of preventing infections.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$191,484
NIH project number1K08AI197049-01A1
Project IDNIH-11451948 on NIH RePORTER

Who could benefit from this research

Could help

Adults who have suffered traumatic brain injury and are at risk for pneumonia, particularly those with signs of immune dysregulation.

Less likely to help

Patients without brain injury or those not at risk for pneumonia would not directly benefit from this study.

What this research studies

After a traumatic brain injury, patients are at high risk for serious lung infections like pneumonia. This project focuses on neutrophils and how their sugar molecules (glycans) may change after injury and affect the body's first-line defense against lung bacteria. By studying the link between brain injury–related immune changes and pneumonia, researchers hope to identify new ways to prevent infection. The work combines clinical observations with laboratory analyses to uncover actionable targets for preventing pneumonia in this vulnerable group.

Why it matters

Potential benefit: If successful, the research could lead to new strategies to reduce pneumonia risk and improve survival for people with traumatic brain injury.

How similar studies have gone: Previous work suggests neutrophil function and glycan patterns influence infection risk, but this specific brain-injury–driven glycomic mechanism is relatively novel.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Seshadri, Anupamaa — Beth Israel Deaconess Medical Center
  • Study coordinator: Seshadri, Anupamaa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.